On Friday, the same day Johnson & Johnson committed to spend $55 billion domestically over the next four years, company officials were in Eastern North Carolina to mark the first major investment ...

Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

The Laredo Cares Spring 2025 Job Fair will be hosted in a partnership with the City of Laredo and Laredo College at Maravillo ...

Grifols has signed a strategic agreement with Inpeco to provide transfusion medicine labs with complete, tailored ...

The global colorectal cancer molecular diagnostics market is poised for significant growth, with projections indicating a remarkable surge to USD 5.07 billion by 2032, according to recent market ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, March 17, 2025. Let’s take a ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...

Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...